Tag Archives: Coronavirus

Criticality of Drug Quality In The Moment Of Truth

Posted on by
Reply

When global health emergencies strike unannounced – in the scale and magnitude of new coronavirus, it shakes the health care system of all countries, in varying degree though, irrespective of the robustness of the economy. In such situation, the robustness … Continue reading →

China Coronavirus And API Sourcing – A Threat… Or An Opportunity For India?

Posted on by
Reply

‘2015 – Year of Active Pharmaceutical Ingredients’ (API), announced the Government of India by a Press Release on February 25, 2015. This came after ascertaining that over-dependence on imports of bulk drugs or API, especially from China, is detrimental to India’s health … Continue reading →